Whan In Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	63,580	43,147	45,366	36,776	64,056
Short-Term Investments	140	519	15,164	12,791	22,966
Trading Asset Securities	-	8,915	17,927	37,725	58,940
Cash & Short-Term Investments	63,720	52,581	78,457	87,292	145,962
Cash Growth	21.18%	-32.98%	-10.12%	-40.20%	24.80%
Accounts Receivable	61,876	70,983	74,526	68,242	61,876
Other Receivables	4,600	4,644	4,340	4,021	1,243
Receivables	66,547	75,709	78,947	72,326	63,201
Inventory	96,322	72,411	54,058	37,060	32,745
Prepaid Expenses	1,674	462.1	501.07	426.78	334.39
Other Current Assets	7.97	134.39	138.51	317.02	169.72
Total Current Assets	228,271	201,297	212,101	197,422	242,412
Property, Plant & Equipment	144,059	149,218	131,211	109,854	46,869
Long-Term Investments	62,981	32,749	19,163	23,901	26,193
Other Intangible Assets	9,292	7,160	5,382	3,176	2,969
Long-Term Deferred Tax Assets	1,947	1,899	171.91	-	-
Other Long-Term Assets	32,334	32,362	33,159	35,002	34,715
Total Assets	478,891	424,706	401,227	369,375	353,189
Accounts Payable	23,213	22,456	18,071	11,966	9,422
Accrued Expenses	3,920	3,049	3,224	2,473	4,171
Current Portion of Leases	396.51	278.24	324.97	186.32	415.86
Current Income Taxes Payable	6,743	2,636	2,683	3,330	5,571
Other Current Liabilities	22,229	13,957	15,725	13,796	11,320
Total Current Liabilities	56,501	42,376	40,028	31,750	30,900
Long-Term Leases	282.48	135.5	307.06	63.62	1,305
Long-Term Deferred Tax Liabilities	-	-	-	368.34	1,098
Other Long-Term Liabilities	1,100	6,192	2,684	3,264	2,660
Total Liabilities	57,884	48,704	43,019	35,446	35,963
Common Stock	9,700	9,700	9,700	9,700	9,700
Additional Paid-In Capital	42,521	21,062	21,062	20,817	21,135
Retained Earnings	368,149	358,861	339,984	314,790	295,449
Treasury Stock	-336.88	-9,669	-9,669	-9,669	-9,669
Comprehensive Income & Other	972.93	-3,952	-2,870	-2,126	324.92
Total Common Equity	421,007	376,002	358,207	333,511	316,939
Minority Interest	-	-	-	416.75	286.26
Shareholders' Equity	421,007	376,002	358,207	333,928	317,226
Total Liabilities & Equity	478,891	424,706	401,227	369,375	353,189
Total Debt	679	413.74	632.03	249.94	1,721
Net Cash (Debt)	63,041	52,167	77,825	87,042	144,241
Net Cash Growth	20.84%	-32.97%	-10.59%	-39.66%	25.68%
Net Cash Per Share	3975.80	3416.99	5097.57	5701.29	9447.84
Filing Date Shares Outstanding	18.48	15.27	15.27	15.27	15.27
Total Common Shares Outstanding	18.48	15.27	15.27	15.27	15.27
Working Capital	171,769	158,921	172,074	165,671	211,512
Book Value Per Share	22776.90	24628.27	23462.75	21845.15	20759.68
Tangible Book Value	411,715	368,841	352,826	330,335	313,970
Tangible Book Value Per Share	22274.17	24159.27	23110.24	21637.11	20565.20
Land	49,677	49,677	49,572	49,726	13,536
Buildings	71,074	71,074	40,938	35,821	24,194
Machinery	27,227	25,822	22,094	18,653	10,919
Construction In Progress	25.6	103.45	18,876	7,590	4,610

Source: S&P Global Market Intelligence. Standard template. Financial Sources.